CART-ddBCMA for multiple myeloma: Interim results from phase I study

被引：1

作者：

Frigault, M. ^{[1
]}

Rosenblatt, J. ^{[2
]}

Raje, N. ^{[1
]}

Cook, D. ^{[1
]}

Gaballa, M. ^{[3
]}

Emmanuel-Alejandro, E. ^{[1
]}

Cornwell, C. ^{[4
]}

Banerjee, K. ^{[4
]}

Rotte, A. ^{[4
]}

Heery, C. ^{[5
]}

Avigan, D. ^{[2
]}

Jakubowiak, A. ^{[6
]}

Bishop, M. ^{[6
]}

机构：

[1] MGH Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA

[2] Beth Israel Deaconess Med Ctr, Canc Ctr, Boston, MA USA

[3] Massachusetts Gen Hosp, Canc Ctr, Surg Oncol Div, Boston, MA USA

[4] Arcellx, Clin & Regulatory Affairs, Gaithersburg, MD USA

[5] Arcellx, Clin Dev Dept, Gaithersburg, MD USA

[6] Univ Chicago Med, Canc Ctr, Chicago, IL USA

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.746

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

620O

引用

页码：S828 / S828

页数：1

共 50 条

[31] Patient Perspectives of Thromboprophylaxis in Multiple Myeloma: Results from the Thromboprophylaxis in Multiple Myeloma (TiMM) study [J].

Sayar, Z. ;

Czuprynska, J. ;

Patel, J. P. ;

Benjamin, R. ;

Roberts, L. N. ;

Patel, R. K. ;

Cornelius, V. ;

Arya, R. .

THROMBOSIS RESEARCH, 2018, 164 :S189-S190

[32] Elotuzumab In Combination with Lenalidomide and Low-Dose Dexamethasone In Patients with Relapsed/Refractory Multiple Myeloma: Interim Results of a Phase 1 Study [J].

Lonial, Sagar ;

Vij, Ravi ;

Harousseau, Jean-Luc ;

Facon, Thierry ;

Moreau, Philippe ;

Leleu, Xavier ;

Mazumder, Amitabha ;

Kaufman, Jonathan L. ;

Westland, Christopher E. ;

Tsao, Claire ;

Singhal, Anil K. ;

Jagannath, Sundar .

BLOOD, 2010, 116 (21) :805-806

[33] A phase I study of belantamab mafodotin in combination with standard of care in newly diagnosed multiple myeloma: an interim analysis of DREAMM-9 [J].

Leypoldt, L. ;

Usmani, S. Z. ;

Mielnik, M. ;

Byun, J. M. ;

Alonso, A. ;

Abdallah, A. -O ;

Garg, M. ;

Quach, H. ;

Min, C. -K ;

Janowski, W. ;

San Miguel, Ocio E. M. ;

Weisel, K. ;

Oriol, A. ;

Sandhu, I ;

Rodriguez-Otero, P. ;

Ramasamy, K. ;

Egger, J. L. ;

Williams, D. ;

Ma, J. ;

Kaisermann, M. C. ;

Hus, M. .

ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 :181-182

[34] Dasatinib in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: Preliminary Results of a Phase I Study [J].

Facon, Thierry ;

Leleu, Xavier ;

Stewart, A. Keith ;

Spencer, Andrew ;

Rowlings, Philip ;

Hulin, Cyrille ;

Attal, Michel ;

Garzon, Felix ;

Bleickardt, Eric ;

Gialelis, Konstantina ;

Tuozzoli, Doreen ;

Derreumaux, Dorninique ;

Sonneveld, Pieter .

BLOOD, 2009, 114 (22) :744-745

[35] Tanespimycin plus bortezomib in patients with relapsed and refractory multiple myeloma: Final results of a phase I/II study [J].

Richardson, P. G. ;

Chanan-Khan, A. ;

Lonial, S. ;

Krishnan, A. ;

Carroll, M. ;

Alsina, M. ;

Albitar, M. ;

Berman, D. ;

Kaplita, S. ;

Anderson, K. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

[36] CARFILZOMIB, BENDAMUSTINE AND DEXAMETHASONE (CBD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: RESULTS OF A PHASE I/II EMN STUDY [J].

Offidani, M. ;

Guenther, A. ;

Gay, F. ;

Engelhardt, M. ;

Gentili, S. ;

Montefusco, V. ;

Patriarca, F. ;

Angelucci, E. ;

Schub, N. ;

Astolfi, M. ;

Poenisch, W. ;

Einsele, H. ;

Sonneveld, P. ;

Boccadoro, M. ;

Corradini, P. ;

Gramatzki, M. .

HAEMATOLOGICA, 2017, 102 :37-37

[37] Phase I results from a phase I/II study of arsenic trioxide (As2O3) and ascorbic acid (AA) in relapsed and chemorefractory multiple myeloma. [J].

Bahlis, NJ ;

Jordan-McMurry, I ;

Grad, JM ;

Reis, I ;

Neel, J ;

Kharfan-Dabaja, MA ;

Eckman, J ;

Goodman, M ;

Fernandez, HF ;

Boise, LH ;

Lee, KP .

BLOOD, 2001, 98 (11) :375A-375A

[38] PHASE-I-II STUDY OF EPIRUBICIN IN MULTIPLE-MYELOMA [J].

CASE, DC ;

ERVIN, TJ ;

GAMS, R ;

SONNEBORN, HL ;

PAUL, SD ;

OLDHAM, FB .

CANCER RESEARCH, 1988, 48 (21) :6246-6248

[39] PHASE-I-II STUDY OF EPIRUBICIN IN MULTIPLE-MYELOMA [J].

CASE, DC ;

ERVIN, TJ ;

GAMS, R ;

SONNEBORN, H ;

PAUL, S ;

OLDHAM, FB .

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 :213-213

[40] AN OBSERVATIONAL POST AUTHORIZATION STUDY ON THE USE OF BORTEZOMIB IN MULTIPLE MYELOMA PATIENTS IN THE NETHERLANDS: RESULTS OF AN INTERIM ANALYSIS [J].

Lokhorst, H. ;

van der Heuls, C. ;

Roerdink, H. ;

De Weerdt, O. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 :615-615

← 1 2 3 4 5 →